Kabra Drugs Ltd

AI
Kabra Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Kabra Drugs Ltd

₹ 22.2 2.78%
21 Aug 12:24 p.m.
kabradrugs.com BSE: 524322
About

Incorporated in 1989, Kabra Drugs Ltd deals in pharmaceutical products, biological API’s and biochemicals.[1]

Key Points

Business Overview:[1]
KDL is in the business of manufacturing Perma
culture and trading in the pharma-related product.

Website BSE
  • Market Cap ₹ 52.6 Cr.
  • Current Price ₹ 22.2
  • High / Low ₹ 35.5 / 15.5
  • Stock P/E 6.91
  • Book Value ₹ 12.5
  • Dividend Yield 0.00 %
  • ROCE 20.8 %
  • ROE 18.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 96.8% CAGR over last 5 years

Cons

  • Company has a low return on equity of 7.79% over last 3 years.
  • Company has high debtors of 279 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.15 19.76 30.42 35.41 46.22
0.12 0.13 0.11 0.37 0.55 0.40 0.53 0.24 7.67 17.72 27.99 34.07 43.43
Operating Profit -0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.53 -0.24 -0.52 2.04 2.43 1.34 2.79
OPM % -7.27% 10.32% 7.99% 3.78% 6.04%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.64 0.02 0.18 0.18 0.11 0.08
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.02 0.02
Profit before tax -0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.53 0.39 -0.50 2.21 2.60 1.42 2.84
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.74% 1.54% 25.35% 25.35%
-0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.54 0.39 -0.50 1.84 2.57 1.06 2.12
EPS in Rs -0.27 -0.30 -0.25 -0.84 -1.25 -0.40 -0.54 0.16 -0.21 0.78 1.08 0.45 0.89
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
8 10 8 2 -0 0 0 0 0 0 0 93 132
8 9 7 3 0 0 0 0 0 1 2 87 123
Operating Profit 0 0 0 -1 -0 -0 -0 -0 -0 -1 -2 5 9
OPM % 6% 4.7% 6% -57% -150% -3,400% 6% 7%
0 0 0 -1 0 0 0 0 0 0 1 0 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 -2 -0 -0 -0 -0 -0 -1 -1 6 9
Tax % 36% 40% 7% 0% 0% 0% 0% 0% 0% 0% 0% 13%
0 0 0 -2 -0 -0 -0 -0 -0 -1 -1 5 8
EPS in Rs 0.16 0.07 0.30 -5.38 -0.36 -0.14 -0.41 -0.43 -0.77 -1.69 -0.46 2.09 3.20
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 25%
5 Years: %
3 Years: %
TTM: 1744%
Compounded Profit Growth
10 Years: 67%
5 Years: 97%
3 Years: 155%
TTM: 823%
Stock Price CAGR
10 Years: 12%
5 Years: 33%
3 Years: 66%
1 Year: 13%
Return on Equity
10 Years: %
5 Years: %
3 Years: 8%
Last Year: 18%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 4 4 4 4 4 4 4 4 4 24 24
Reserves -2 -2 -2 -4 -4 -4 -5 -5 -5 -3 1 6
3 2 2 1 1 1 1 1 1 2 0 1
3 4 2 1 1 1 1 0 0 2 0 56
Total Liabilities 9 9 6 2 1 1 1 1 1 5 25 86
3 3 2 0 0 0 0 0 0 0 0 1
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
6 6 4 2 1 1 1 1 1 5 25 85
Total Assets 9 9 6 2 1 1 1 1 1 5 25 86

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 0 0 -0 -0 -0 -0 -0 -0 -0 -5 -9
-0 -0 0 2 0 0 0 0 0 0 -0 -1
1 -0 -0 -1 0 -0 0 0 0 3 23 0
Net Cash Flow 0 -0 0 0 -0 0 0 -0 0 3 19 -11
Free Cash Flow -0 -0 0 1 -0 -0 -0 -0 -0 -0 -5 -10
CFO/OP -38% 67% 73% 10% 138% 100% 167% 72% 100% 28% 274% -173%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 198 204 141 254 -11,406 279
Inventory Days 26 16 17 0 0 0
Days Payable 130 140 97
Cash Conversion Cycle 94 80 61 254 -11,406 279
Working Capital Days 86 70 34 -28 -912 66
ROCE % 4% 4% 7% -44% -19% -9% -27% -29% -53% -43% -8% 21%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees on Rolls
employees

Log in to view insights

Please log in to see hidden values.

Login

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
100.01% 100.01% 100.01% 100.01% 100.01% 100.00% 100.00% 100.01% 100.00% 100.00% 100.00% 100.00%
No. of Shareholders 7,4157,3967,3647,3367,3677,3437,4357,4498,0988,8629,1859,680

Documents

Announcements

Annual reports